Technology areas: Biotechnology & Pharmaceuticals • Communications • Transportation, E-Commerce & Mechanical Systems
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days
Politecnico di Milano currently manages 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These cases are assigned to 3 distinct examiners, including SATCHER, DION JOHN, who is the busiest examiner for the portfolio. The matters are distributed across 3 distinct art units.
The presence of 3 pending office actions and 3 distinct examiners indicates that each case is being reviewed by a different individual. SATCHER, DION JOHN is responsible for 1 pending case, which shows that the workload is spread across the assigned staff. This structure requires the university to adapt to 3 different examination styles simultaneously.
With 3 distinct art units involved, the technical and procedural expectations will vary across the Biotechnology & Pharmaceuticals filings. Since SATCHER, DION JOHN handles 1 pending case, the practitioner must maintain separate communication channels for each matter. The prosecution strategy should focus on the specific requirements of the 3 distinct art units while addressing the unique feedback from each examiner.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SATCHER, DION JOHN | 1 | 82.1% | +16.7% |
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.7% |
| BURGESS, MARC R | 1 | 33.8% | +24.2% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18857089 | Method to estimate in real time the likelihood of success of thrombectomy surgery | SATCHER, DION JOHN | — |
| 18150694 | DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT | HELM, CARALYNNE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18019662 | INFLATABLE LIFE JACKET | BURGESS, MARC R | 22d overdue |
| 18556992 | GEL FOR THE REGENERATION OF MUCOSAE | HOFFMAN, SUSAN COE | 26d |
| 18857089 | Method to estimate in real time the likelihood of success of thrombectomy surgery | SATCHER, DION JOHN | — |
| 18150694 | DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT | HELM, CARALYNNE E | — |
| Art Unit | Apps |
|---|---|
| 2676 | 1 |
| 1655 | 1 |
| 3615 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18857089 | Method to estimate in real time the likelihood of success of thrombectomy surgery | SATCHER, DION JOHN | 2676 | §103§112 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18556992 | GEL FOR THE REGENERATION OF MUCOSAE | HOFFMAN, SUSAN COE | 1655 | §103 | Final Rejection | 26d | Pending | Oct 24, 2023 |
| 18019662 | INFLATABLE LIFE JACKET | BURGESS, MARC R | 3615 | §103 | Final Rejection | 22d overdue | Pending | Feb 03, 2023 |
| 18150694 | DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT | HELM, CARALYNNE E | 1615 | §103 | Final Rejection | — | Pending | Jan 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPolitecnico di Milano has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Dion John Satcher has the most, with 1 of Politecnico di Milano's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
